June 2025, From the Field
On May 12, 2025, the U.S. and China significantly rolled back tariffs on each other’s goods for an initial 90-day period. The U.S. reduced tariffs on Chinese goods from 145% to 30%, while China cut retaliatory tariffs on U.S. goods from 125% to 10% for the period. Additionally, President Donald Trump’s revised executive order lowered tariffs on small packages valued under USD 800 from 120% to 54%. While further developments in trade talks are expected ahead, the truce was well received by the markets, with the MSCI China Index climbing 17% since April 7, 2025, lifting year-to-date returns to 15% (as of April 16, 2025).
"Regardless of the outcome of the trade deal, several trends are emerging, poised to reshape the global economic landscape…."
Past performance is not a guarantee or a reliable indicator of future results.
Index performance is for illustrative purposes only and is not indicative of any specific investment. Investors cannot invest directly in an index.
Sources: MSCI (see Additional Disclosures), returns in USD. Financial data and analytics provider, FactSet. Copyright 2025 FactSet. All Rights Reserved.
As of April 30, 2025.
Sources: MSCI (see Additional Disclosures), Goldman Sachs Global Investment Research. Financial data and analytics provider, FactSet. Copyright 2025 FactSet. All Rights Reserved.
At the expiry of the 90-day window, we might see further escalation or de‑escalation. Regardless of the outcome of the trade deal, several trends are emerging, poised to reshape the global economic landscape and redefine investment opportunities.
The U.S. is advancing its reindustrialization agenda, with tariff policies as a cornerstone. This strategy prioritizes strategic sectors such as semiconductors, electric vehicles, pharmaceuticals, steel, and shipbuilding. As a result, global supply chains in these industries are undergoing significant disruption and reconfiguration. The highly integrated, globalized supply chain model is giving way to a more regionalized yet interconnected framework. This shift presents challenges for all economies, but those with robust domestic markets and comprehensive industrial ecosystems are better equipped to adapt.
With lingering uncertainties from tariffs, it’s helpful to assess their potential impact on the Chinese economy.
Over the past decade, China has implemented proactive measures to mitigate external pressures. The Belt and Road Initiative has broadened access to global markets, diversifying trade partnerships, while the “dual circulation” strategy has fortified domestic economic resilience. Additionally, breakthroughs in critical technologies have eased supply‑side bottlenecks, and deleveraging in the financials and real estate sectors has reduced systemic risks, positioning China to better absorb potential shocks.
The economic impact from tariffs is moderated by China’s reduced reliance on U.S. markets. In 2024, exports to the U.S. (including re-exports) accounted for approximately 3% of China’s gross domestic product (GDP), down from 6% in 2010, reflecting a significant shift in trade dynamics.
At the corporate level, the impact of tariff escalation is limited for most Chinese firms, with U.S. exports comprising only around 1% of the average revenue of listed companies—one of the lowest U.S. exposures globally. Escalation may exacerbate slower economic growth, but firms are adapting by accelerating globalization strategies.
Since 2018, many have pivoted from export-focused models to globalized operations, a trend likely to intensify. Companies with advanced technologies and operational agility are well placed to seize opportunities, even in a volatile trade environment, supporting long-term equity resilience.
"Enhancing domestic consumption aligns with China’s internal needs…."
2024 annual data.
Sources: MSCI (see Additional Disclosures), Goldman Sachs Global Investment Research. Financial data and analytics provider, FactSet. Copyright 2025 FactSet. All Rights Reserved.
Companies with forward-looking strategies and flexible approaches stand to gain market share as the market evolves. Staying calm and conducting objective fundamental analysis can help investors uncover undervalued investment opportunities in China with significant potential.
May 2025
From the Field
Article
1 Source: China Pharmaceutical Industry Research Development Association. As of April 5, 2025.
International investments can be riskier than U.S. investments due to the adverse effects of currency exchange rates, differences in market structure and liquidity, as well as specific country, regional, and economic developments. These risks are generally greater for investments in emerging markets.
Additional Disclosures
Financial data and analytics provider FactSet. Copyright 2025 FactSet. All Rights Reserved.
MSCI and its affiliates and third-party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
Important Information
This material is provided for informational purposes only and is not intended to be investment advice or a recommendation to take any particular investment action.
The views contained herein are those of the authors as of June 2025 and are subject to change without notice; these views may differ from those of other T. Rowe Price associates.
This information is not intended to reflect a current or past recommendation concerning investments, investment strategies, or account types, advice of any kind, or a solicitation of an offer to buy or sell any securities or investment services. The opinions and commentary provided do not take into account the investment objectives or financial situation of any particular investor or class of investor. Please consider your own circumstances before making an investment decision.
Information contained herein is based upon sources we consider to be reliable; we do not, however, guarantee its accuracy. Actual future outcomes may differ materially from any estimates or forward-looking statements provided.
Past performance is not a guarantee or a reliable indicator of future results. All investments are subject to market risk, including the possible loss of principal. All charts and tables are shown for illustrative purposes only.
T. Rowe Price Investment Services, Inc., distributor. T. Rowe Price Associates, Inc., investment adviser. T. Rowe Price Investment Services, Inc., and T. Rowe Price Associates, Inc., are affiliated companies.
© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.